GLP-1 medicines are often discussed by brand name, active ingredient, and drug class. This can be confusing because the same active ingredient may appear under more than one brand, and some medicines used in the same conversation are not exactly identical in how they work.
The active ingredient is the drug substance. The brand name is the commercial name used on packaging. A prescriber will usually care about both, because the active ingredient explains what the medicine is, while the brand may indicate the licensed use, formulation, device, or dose schedule in a particular country.
Common names people may see
Semaglutide is the active ingredient in brands such as Ozempic, Wegovy, and Rybelsus. Ozempic and Rybelsus are commonly associated with type 2 diabetes treatment; Wegovy is commonly associated with weight management. The same active ingredient does not mean the products are interchangeable.
Tirzepatide is the active ingredient in Mounjaro and Zepbound in some markets. Tirzepatide acts on GIP and GLP-1 receptors, so it is often discussed alongside GLP-1 medicines, even though it is more precisely described as a dual GIP/GLP-1 receptor agonist.
Liraglutide is the active ingredient in brands such as Victoza and Saxenda. Dulaglutide is the active ingredient in Trulicity. Exenatide appears in brands such as Byetta and Bydureon. Lixisenatide appears in brands that vary by country. Some combination products include a GLP-1 medicine plus insulin.
Why tracking names matters
When recording your medicine history, write the brand name, active ingredient if known, route, and date started. If you have used a compounded or non-standard product, record exactly what the label says, including concentration, pharmacy name, instructions, and any added ingredients.
Do not use names as a switching guide
Do not assume two products are equivalent because they share a similar name or are discussed in the same online forum. Do not switch between brands, compounded products, pens, tablets, or vials without prescriber and pharmacist guidance.
If a label is unclear, the safest next step is to ask the prescribing clinician or dispensing pharmacy to clarify it. Guessing from online conversion charts can lead to serious dosing errors.